Abstract
While pediatric headache is a common and often troublesome concern, in many cases, it is simply one part of the overarching concern or condition. While these patients are more prone to comorbid neurological and psychiatric conditions as discussed in the prior chapter, they are also more likely to have other general comorbidities that, in some cases, may go unrecognized and as such untreated for some time. Dysautonomia and atopy are two broad categories of conditions that are commonly seen with pediatric headache patients that often lead to frustrations, especially when not recognized as comorbidities, but also may lead to opportunity when considered as once these are recognized the treatment approach and options may change, yielding a more successful and satisfying outcome for all. In this chapter, the crossover between dysautonomia and atopy with headache in the pediatric population will be explored in attempts to help prevent a missed opportunity when thinking about the complete pediatric patient, rather than simply just a pediatric headache patient.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ellinger A, Weisbrot B. Neurologic differential diagnosis: a case-based approach. Cambridge: Cambridge University Press; 2014. p. 72–81.
Khurana R, Eisenberg L. Orthostatic and non-orthostatic headache in postural tachycardia syndrome. Cephalalgia. 2010;31(4):409–15.
Thijs RD, Kruit MC, van Buchem MA, Ferrari MD, Launer LJ, van Dijk JG. Syncope in migraine. The population-based CAMERA study. Neurology. 2006;66:1034–7.
Axelrod F, Chelimsky G, Weese-Mayer D. Pediatrics. 2006;118:309–21.
Arnold A, Ng J, Raj S. Postural tachycardia syndrome—diagnosis, physiology, and prognosis. Auton Neurosci. 2018;215:3–11.
Stiles L.. http://www.dysautonomiainternational.org/pdf/PhysicianPatientInteractionInPOTS.pdf.
Grubb, Kanjwal, Kosinski. 2006.
Mack K, Johnson J, Rowe P. Orthostatic intolerance and the headache patient. Semin Pediatr Neurol. 2010;17:109–16.
Goodman B. Evaluation of postural tachycardia syndrome. Auton Neurosci. 2018;215:12–9.
Mizumaki K. Postural orthostatic tachycardia syndrome. J Arrhythmia. 2011;27(4):289–306.
Oner T, Guven B, Tavli V, Mese T, Yilmazer MM, Demirpense S. Postural orthostatic tachycardia syndrome (POTS) and vitamin B12 deficiency in adolescents. Pediatrics. 2014;133:e138–42.
Miglis M, Barwick F. Sleep disorders in patients with postural tachycardia syndrome: a review of the literature and guide for clinicians. Auton Neurosci. 2018;215:62–9.
Benarroch E. Postural tachycardia syndrome: a heterogeneous and multifactorial disorder. Mayo Clin Proc. 2012;2010(87):1214–25.
Abu-Arafeh I, Razak S, Sivaraman B, Graham C. Prevalence of headache and migraine in children and adolescents: a systematic review of population-based studies. Dev Med Child Neurol. 2010;52:1088–97.
Wig R, Oakley C. Dysautonomia and headache in the pediatric population. Headache. 2019;59:1582–8.
Gelfand A, Reider A, Goadsby P. Cranial autonomic symptoms in pediatric migraine are the rule, not the exception. Neurology. 2013;81:431–6.
Cook G Jr, Sandroni P. Management of headache and chronic pain in POTS. Auton Neurosci. 2018;215:37–45.
Wieling W, van Lieshout J, van Leeuwen A. Physical manoeuvres that reduce postural hypotension in autonomic failure. Clin Autonom Res. 1993;3:57–65.
Kuriachan V, Sheldon R, Platanov M. Evidence-based treatment for vasovagal syncope. Heart Rhythm. 2008;5:1609–14.
Stewart J, Ocon A, Medow M. Ascorbate improves circulation in postural tachycardia syndrome. Am J Physiol Heart Circ Physiol. 2011;301:H1033–42.
Raj S, Black B, Biaggioni I, et al. Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more. Circulation. 2009;230:725–34.
Sillanpaa M, Aro H. Headache in teenagers: comorbidity and prognosis. Funct Neurol. 2000;15 Suppl 3:116–21.
Eidlitz-Markus T, Zolden S, Haimi-Cohen Y, Zeharia A. Comparison of comorbidities of migraine and tension headache in a pediatric headache clinic. Cephalalgia. 2017;37:1135–44.
Ozge A, Yalin OO. Chronic migraine in children and adolescents. Curr Pain Headache Rep. 2016;20(2):14.
Ozge A, Oksuz N, Ayta S, Uluduz D, Yildirim V, Toros F, Tasdelen B. Atopic disorders are more common in childhood migraine and correlated headache phenotype. Pediatr Int. 2014;56:868–72.
Graif Y, Shohat T, Machlut Y, Forkash R, Chaiter Y. Association between asthma and migraine: a cross-sectional study of over 110 000 adolescents. Clin Respir J. 2018;12:2491–6.
Martin VT, Taylor F, Gebhardt B, et al. Allergy and immunotherapy: are they related to migraine headache? Headache. 2011;51:8–20.
Munoz-Jareno N, Fernandez-Mayoralas DM, Martinez-Cervell C, Campos-Castello J. Relationship between migraine and atopy in childhood: a retrospective case-control study. Rev Neurol. 2011;53:713–20.
Ozge A, Kuwabara K. Comorbidity of migraine with asthma and other atopic disorders. In: Guidetti V, Arruda MA, Ozge A, editors. Headache and comorbidities in childhood and adolescence. Cham: Springer; 2017. p. 85–93.
Ozge A, Ozge C, Ozturk C, et al. The relationship between migraine and atopic disorders—the contribution of pulmonary function tests and immunological screening. Cephalalgia. 2006;26:172–9.
Mortimer MJ, Kay J, Gawkrodger DJ, Jaron A, Barker DC. The prevalence of headache and migraine in atopic children: an epidemiological study in general practice. Headache. 1993;33:427–31.
Ozge A, Ozturk C, Dora B, et al. Is there an association between migraine and atopic disorders? J Neurol Sci. 2008;25:136–47.
Bellamy JL, Cady RK, Durham PL. Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients. Headache. 2006;46:24–33.
Lai TH, Fuh JL, Wang SJ. Cranial autonomic symptoms in migraine: characteristics and comparison with cluster headache. J Neurol Neurosurg Psychiatry. 2009;80:1116–9.
Riesco N, Perez-Alvarez AI, Verano L, et al. Prevalence of cranial autonomic parasympathetic symptoms in chronic migraine: usefulness of a new scale. Cephalalgia. 2016;36:346–50.
Holland S, Silberstein SD, Freitag F, Dodick DW, Argoff C, Ashman E. Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults. Neurology. 2012;78:1346–53.
Brandes JL, Visser H, Farmer MV, et al. Montelukast for migraine prophylaxis: a randomized, double-blind, placebo-controlled study. Headache. 2004;44:581–6.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Feldman, D., Williams, R.P. (2022). Dysautonomia and Atopy in Pediatric Headache Patients. In: Oakley, C.B. (eds) Pediatric Headache. Springer, Cham. https://doi.org/10.1007/978-3-031-13931-4_8
Download citation
DOI: https://doi.org/10.1007/978-3-031-13931-4_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-13930-7
Online ISBN: 978-3-031-13931-4
eBook Packages: MedicineMedicine (R0)